MarketPulse

surgical robotics

7 articles
The Motley FoolThe Motley Fool··Reuben Gregg Brewer

Medtronic's Dividend Fortress Rivals Intuitive Surgical's Growth at Half the Price

Medtronic offers a more attractive valuation (22x P/E vs. 55x) than Intuitive Surgical, with 3.6% dividend yield and Hugo robot growth potential.
MDTISRGvaluationdividend stocks
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Computer Vision in Healthcare Poised for 7x Growth, Reaching $33.4B by 2036

Global healthcare computer vision market projected to surge from $4.37B in 2026 to $33.4B by 2036, driven by AI diagnostics and radiologist shortages.
NVDAMSFTGOOGGOOGLSYK+5artificial intelligenceAsia Pacific growth
The Motley FoolThe Motley Fool··Reuben Gregg Brewer

The Recurring Revenue Engine: Why Intuitive Surgical's 580% Surge Masks Its True Strength

Intuitive Surgical's decade-long 580% rally stems from recurring revenue—75% of total—from instruments and services, not robot sales alone.
ISRGmedical devicesrecurring revenue
Investing.comInvesting.com··Thomas Hughes

J&J Signals Recovery Path With 9.9% Revenue Growth Despite Patent Headwinds

J&J reported 9.9% Q1 revenue growth with raised guidance, though EPS fell 2.5% due to patent losses. Technical setup suggests 20% upside potential supported by strong pipeline expectations.
JNJrevenue growthinstitutional ownership
The Motley FoolThe Motley Fool··Reuben Gregg Brewer

Healthcare Giants BDX and MDT Offer Dividend Appeal Below $1,000 Each

Becton Dickinson and Medtronic offer attractive dividend yields of 2.4% and 2.9%, trading below $1,000 with growth potential amid sector pessimism.
MDTISRGBDXdividend stockslong-term investing
The Motley FoolThe Motley Fool··Reuben Gregg Brewer

Medtronic's FDA-Approved Hugo Robot Could Unlock Major Growth as Valuation Gap Widens

Medtronic ($MDT) wins FDA approval for Hugo surgical robot, trading at 27x P/E versus competitor Intuitive Surgical ($ISRG) at 64x, offering potential upside with 2.9% dividend yield.
MDTISRGgrowth opportunityvaluation
The Motley FoolThe Motley Fool··Reuben Gregg Brewer

Intuitive Surgical Posts Double-Digit Growth Despite GLP-1 Drug Market Spotlight

Intuitive Surgical posts double-digit growth in 2025 with 12% installed base expansion and 18% surgery increase, unaffected by GLP-1 drug market competition.
LLYNVOISRGGLP-1 drugsgrowth stocks